Elizabeth Homans

Insider Reports History

Entity
Individual
Location
C/O Lyell Immunopharma, Inc., 400 East Jamie Court, Suite 301, South San Francisco, CA
Signature
/s/ Heather Turner, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Homans:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Executive Officer, Director Option (right to buy) 1.48M Mar 16, 2022 Direct

Insider Reports Filed by Elizabeth Homans

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Mar 16, 2022 1 $0 4 Mar 18, 2022 Chief Executive Officer, Director
LYEL Lyell Immunopharma, Inc. Sep 13, 2021 1 $0 4 Sep 14, 2021 Chief Executive Officer, Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Chief Executive Officer, Director